Herpes Transmission: Swedish Specialist joins call for wider HSV testing

A study of patients attending sexual health clinics in Gothenburg, including a sample of over 1000 patients both male and female showed that more than 20% of women and 10% of men were infected with HSV-2 genital herpes. Only 40% of infected patients were aware that they had herpes [...]

Herpes Research: HSV-2 genital Herpes Is Far Less Infectious When No Symptoms Are Present

A recent study into HSV shedding carried out by the University of Washington and the Fred Hutchinson Cancer Research Center confirms earlier findings that the HSV-2 virus can and does shed among asymptomatic carriers.

In scientific tests it was found that the shedding period for asymptomatic carriers was a little over half that of [...]

Herpes research: new advances for HSV-1 herpes treatment (Cellectis)

Paris based Cellectis therapeutics announced last January that a team of scientists had successfully used its Meganucleases to block an HSV-1 herpes infection. This is the first proof that meganucleses can be used to prevent viral infection.

The implication of this new technique for preventing the spread of virus has the potential to revolutionize [...]

Cure Herpes with Food extracts?

Image via Wikipedia

The Journal of Biological chemistry reports that recent research into lectins found in natural foodstuffs has discovered that these natural proteins that bind to sugars can also bind to infected cells in the body. Lectins extracted from bananas have been found to bind to cells infected with HIV, for [...]

Herpes Research: African herpes simplex virus strain may be more virulent

Testing mouse model strains of the HSV-2 virus from both African and US sources, the Harvard research team discovered that vaccines were far more efficacious against the US strain than the African strain. [...]

Herpes Drug Manufacturer Takes His Patient as Guinea Pigs?

British pharmaceutical giant GlaxoSmithklineBeecham (GSK), manufacturer of the anti-herpes drug Valtrex ®, was recently investigated in respect of its anti-diabetes drug, Avandia. This drug has been known to increase the risk of heart attack [...]

Herpes Treatment: Is Eye Herpes Suppressive Therapy Worth It?

A recent study has thrown up a possible link between prophylactic anti-viral herpes treatments and recurring ocular disorders provoked by the herpes virus.

Keith Baratz M.D and his colleagues at the Mayo clinics of Rochester, MN and Jacksonville, FL conducted a retrospective analysis of patients covering a 32 year period and found that herpes [...]

Herpes drugs and pregnancy: most common anti-herpetic drugs did not increase risk of birth defect in a new study

A recent study in the August 25 issue of JAMA conducted in Denmark concluded that the use of the three most common herpes drugs; acyclovir, valacyclovir, and famciclovir did not increase the risk of major birth defects for mothers who took them during the first trimester of pregnancy. [...]

Research into ‘Super Herpes Virus’ Leads to a Herpes Vaccine

A study reinforces the difficulties in formulating a successful vaccine against CMV, but on a positive note, if CMV could be used as a viral vector in the development of vaccine against HIV, Herpes, Hepatitis C and other viruses affecting the immune system, then unlike other viral vectors which may be used only once (due to their detection and future elimination by killer T cells). CMV could be used repeatedly to stimulate an immune response. [...]

Herpes drugs : Emory Institute teams with Zirus in anti-viral development push

Emory Institute of Drug Discovery has teamed up with biotechnology company Zirus Inc. in an effort to produce up-to-the-minute anti viral drugs to combat such diseases as HIV, Herpes and even the common cold virus. [...]